Avaleht › Crohni tõbi › Kansas
Crohni tõbi kliinilised uuringud osariigis Kansas
11 uuringut haiguse Crohni tõbi jaoks otsivad osalejaid osariigis Kansas.
Linnad osariigis Kansas
Ametlik uuringutekst (inglise keeles)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
- University of Kansas Medical Center ( Site 5091), Kansas City
- Cotton O'Neil Digestive Health Center ( Site 5033), Topeka
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 2. okt 2026 · NCT06430801A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Hutchinson Clinic, Hutchinson
VärbamineFaas 4
Vanused 18–80 · Kõik sood · Uuendatud 30. sept 2026 · NCT06581328A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Cotton-O'Neil Clinical Research Center, Topeka
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07499232A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
- Kansas Gastroenterology, LLC, Wichita
VärbamineFaas 2/3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. sept 2026 · NCT07196722A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center, Kansas City
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT06233461Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of Kansas Clinical Research Center, Fairway
- HaysMed, Hays
- University of Kansas Cancer Center, Kansas City
- ja veel 7
VärbamineFaas 1
Vanused 18 ja vanemad · Kõik sood · Uuendatud 23. sept 2026 · NCT03816345An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- University of Kansas Medical Center-Site Number: 8400110, Kansas City
VärbamineFaas 3
Vanused 16–80 · Kõik sood · Uuendatud 23. sept 2026 · NCT07184931A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07483073A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
- Cotton O'Neil Digestive Health Center, Topeka
VärbamineFaas 2
Vanused 18–80 · Kõik sood · Uuendatud 22. sept 2026 · NCT07483099A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
- University of Kansas Medical Center, Kansas City
- Cotton ONeil Clinical Research Center, Topeka
VärbamineFaas 4
Vanused 18–70 · Kõik sood · Uuendatud 9. sept 2026 · NCT06045754A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
- Investigational Site Number: 8400006, Kansas City
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 27. märts 2026 · NCT06958536Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.